“Doesn't that just open the door for them to take LL and distribute as they see fit(without regards to the company's profiability), for critically ill patients of any of LL's current or future indications?”

I’m not sure how the process works, but I doubt the government’s plan is to distribute leronlimab “as they see fit” or for other indications. That makes zero sense. OWS is for COVID19 only and the U.S. government wants to get a vaccine and therapeutic to the market.